| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 01/16/2002 | EP0790246B1 Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 01/15/2002 | US6339161 Used in addition polymerization as polymerization catalyst |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/15/2002 | CA2054209C Antihyperlipidemic and antiatherosclerotic urea compounds |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | DE10030646A1 Indigo-Derivate Indigo derivatives |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170295A1 Thiocarbonates as flavour precursors |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | EP1169315A2 Method for producing amidines |
| 01/09/2002 | CN1330289A Optical enhancement right photoetching rubber composite and sulfonium salt |
| 01/09/2002 | CN1330071A Synthetic method for benzo [b] thiophene derivative |
| 01/08/2002 | US6337417 Imidoyl chloride derivative chemical intermediates that are not harmful to crops |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | US6337346 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 01/08/2002 | US6337306 Herbicides for agriculture |
| 01/08/2002 | CA2216100C Process for 2-substituted benzo¬b|thiophene compounds and intermediates thereof |
| 01/08/2002 | CA2143263C Orally administrable raloxifene formulations |
| 01/08/2002 | CA2019622C Substituted arylamines and heteroarylamines, their preparation process and pharmaceutical composition containing them |
| 01/03/2002 | WO2002000641A2 Spla2 inhibitors |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000602A1 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/03/2002 | WO2002000180A2 Agents for colouring keratin fibres, containing derivatives of benzo[b]furane-3-one and/or benzo[b]thiophene-3-one |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2000058282A3 Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002187 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin-resistance and hyperglycemia |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | US20020002168 Heterocyclic carboxamides |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | US20020002150 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167487A1 Organic material undergoing light-induced phase transition |
| 01/02/2002 | EP1167349A1 Chemical amplifying type positive resist composition and sulfonium salt |
| 01/02/2002 | EP1165721A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
| 01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP1123286A4 Sulfolane and process therefor |
| 01/02/2002 | EP0938488B1 Phosphine ligands |
| 01/02/2002 | CN1076968C Use of benzo-thiophene compound for preparing medicine for inhibiting bone prosthesis degeneration |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335367 Fungicidal and insecticidal benzyloxy cyclopropyl substituted aromatic compounds |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 12/27/2001 | WO2001098310A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/27/2001 | WO2001098292A1 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001098264A1 Macrophage scavenger receptor antagonists |
| 12/27/2001 | WO2001098262A1 Amidine derivatives as selective antagonists of nmda receptors |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001032646A3 Sulfonamide derivatives |
| 12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 12/27/2001 | US20010054207 p-aminophenol derivative compounds and dye compositions containing same |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2411963A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/26/2001 | CN1076726C Regeneration process for inferior sulfolane |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333346 Aminofuranoneureas or thioureas 4-amino-2(5h)-thiophenones as antitumor agents |
| 12/25/2001 | US6333337 Potassium channel inhibitors |
| 12/25/2001 | US6333082 Liquid crystalline (E,E)-butadiene compounds and mixtures and devices containing such compounds |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096289A1 Sulfonamide derivatives |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001056554A3 Use of retinoid-type compounds as antibacterial agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | WO2001019770A3 Rxr modulators with improved pharmacologic profile |
| 12/20/2001 | US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 12/20/2001 | US20010053758 Methods and compositions for the treatment and prevention of lung disease |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2411811A1 Sulfonamide derivatives |
| 12/20/2001 | CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/19/2001 | EP1163553A1 Oxime derivatives and the use thereof as photoinitiators |
| 12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 12/19/2001 | EP1163215A1 Amino-thio-acrylonitriles as mek inhibitors |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |